SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mona Wagdy Ayad, Amany A. Elbanna, Dalia A. Elneily, Amany S. Sakr, Association of BAFF −871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients, Molecular Diagnosis & Therapy, 2015, 19, 2, 99

    CrossRef

  2. 2
    Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady, Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients, Journal of Interferon & Cytokine Research, 2015, 150413140039004

    CrossRef

  3. 3
    David D. Kim, David W. Hutton, Ahmed A. Raouf, Mohsen Salama, Ahmed Hablas, Ibrahim A. Seifeldin, Amr S. Soliman, Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence, Global Public Health, 2015, 10, 3, 296

    CrossRef

  4. 4
    Sayed F. Abdelwahab, Zainab Zakaria, Maha Sobhy, Shaimaa Hamdy, Mohamed A. Mahmoud, Nabiel Mikhail, Walaa R. Allam, Eman Rewisha, Imam Waked, Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response, Archives of Virology, 2015,

    CrossRef

  5. 5
    Lenka Benova, Susanne F. Awad, F. DeWolfe Miller, Laith J. Abu-Raddad, Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt, Hepatology, 2015, 61, 3
  6. 6
    Siew-Lin Ngui, Lisa Brant, Peter V. Markov, John-Paul Tung, Oliver G. Pybus, Chong-Gee Teo, Mary E. Ramsay, Hepatitis C virus genotype 4 in England: Diversity and demographic associations, Journal of Medical Virology, 2015, 87, 3
  7. 7
    E. Loffredo-Verde, I. Abdel-Aziz, J. Albrecht, N. El-Guindy, M. Yacob, A. Solieman, U. Protzer, D. H. Busch, L. E. Layland, C. U. Prazeres da Costa, Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype, Parasite Immunology, 2015, 37, 2
  8. 8
    Joachim Richter, Johannes G Bode, Dirk Blondin, Gerald Kircheis, Ralf Kubitz, Martha C Holtfreter, Irmela Müller-Stöver, Matthias Breuer, Falk Hüttig, Gerald Antoch, Dieter Häussinger, Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt, The Lancet Infectious Diseases, 2015, 15, 6, 731

    CrossRef

  9. 9
    Davide Ghinolfi, Hanan G. El Baz, Elio Borgonovi, Amr Radwan, Ola Laurence, Hanan A. Sayed, Paolo De Simone, Moaz Abdelwadoud, Alessandro Stefani, Sanaa S. Botros, Franco Filipponi, A model for southern mediterranean research institute self-assessment: A SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt), Arab Journal of Gastroenterology, 2014, 15, 3-4, 92

    CrossRef

  10. 10
    Nabeen C. Nayak, Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesis, Current Medicine Research and Practice, 2014, 4, 2, 62

    CrossRef

  11. 11
    Imran Shahid, Waleed Hassan ALMalki, Muhammad Hassan Hafeez, Sajida Hassan, Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies, Critical Reviews in Microbiology, 2014, 1

    CrossRef

  12. 12
    M. Trubnikov, P. Yan, J. Njihia, C. Archibald, Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysis, CMAJ Open, 2014, 2, 4, E281

    CrossRef

  13. 13
    Ramareddy V. Guntaka, Mythili K. Padala, Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer, ISRN Virology, 2014, 2014, 1

    CrossRef

  14. 14
    James C. Iles, Jayna Raghwani, G.L. Abby Harrison, Jacques Pepin, Cyrille F. Djoko, Ubald Tamoufe, Matthew LeBreton, Bradley S. Schneider, Joseph N. Fair, Felix M. Tshala, Patrick K. Kayembe, Jean Jacques Muyembe, Samuel Edidi-Basepeo, Nathan D. Wolfe, Peter Simmonds, Paul Klenerman, Oliver G. Pybus, Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa, Virology, 2014, 464-465, 233

    CrossRef

  15. 15
    Sami A. Gabr, Ahmad H. Alghadir, Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers, VirusDisease, 2014, 25, 1, 91

    CrossRef

  16. 16
    Diego F. Cuadros, Adam J. Branscum, F. DeWolfe Miller, Laith J. Abu-Raddad, Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications, Hepatology, 2014, 60, 4
  17. 17
    J. P. Webster, D. H. Molyneux, P. J. Hotez, A. Fenwick, The contribution of mass drug administration to global health: past, present and future, Philosophical Transactions of the Royal Society B: Biological Sciences, 2014, 369, 1645, 20130434

    CrossRef

  18. 18
    Tarik el Scheich, Martha C. Holtfreter, Hendrik Ekamp, Daman D. Singh, Rodrigo Mota, Christoph Hatz, Joachim Richter, The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years, Parasitology Research, 2014, 113, 11, 3915

    CrossRef

  19. 19
    Tahany M. Shams, Mohamed F. Hassan, Amany M. Hassan, An immunohistochemical study of T helper 17 cells in hepatitis C viral infection with or without bilharziasis, Egyptian Liver Journal, 2013, 3, 3, 73

    CrossRef

  20. 20
    T Jake Liang, Current progress in development of hepatitis C virus vaccines, Nature Medicine, 2013, 19, 7, 869

    CrossRef

  21. 21
    Mohamed K. Shaker, Heba M. Abdella, Mohamed O. Khalifa, Ahmed K. El Dorry, Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases, Liver International, 2013, 33, 10
  22. 22
    Mones M. Abu Shady, Yasser E. Nassef, Manal Mansour, Essam M. Galal, Manal A. Hamed, Evaluation of the role of vitamin D levels in predicting chronic liver disease development in a group of Egyptian children infected with the hepatitis C virus, Medical Research Journal, 2013, 12, 2, 69

    CrossRef

  23. 23
    Gamal Esmat, Aisha Elsharkawy, Wafaa El Akel, Ahmed Fouad, Karem Helal, Mostafa Kamal Mohamed, Dina Attia, Hany Khattab, Wahid Doss, Sameh Labib, Fibroscan of chronic HCV patients coinfected with schistosomiasis, Arab Journal of Gastroenterology, 2013, 14, 3, 109

    CrossRef

  24. 24
    Bassel K. El-Zorkany, Sherif M. Gamal, Sherine A. El-Mofty, Frequency and causes of discontinuation of methotrexate in a cohort of Egyptian patients, The Egyptian Rheumatologist, 2013, 35, 2, 53

    CrossRef

  25. 25
    David L Thomas, Global control of hepatitis C: where challenge meets opportunity, Nature Medicine, 2013, 19, 7, 850

    CrossRef

  26. You have free access to this content26
    Douglas F. Johnson, Karin Leder, Joseph Torresi, Hepatitis B and C Infection in International Travelers, Journal of Travel Medicine, 2013, 20, 3
  27. 27
    Sayed F. Abdelwahab, Mohamed Hashem, Iman Galal, Maha Sobhy, Tamer S. Abdel-Ghaffar, Gehan Galal, Nabiel Mikhail, Samer S. El-Kamary, Imam Waked, G. Thomas Strickland, Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection, Journal of Clinical Virology, 2013, 57, 1, 24

    CrossRef

  28. 28
    Menka M. Sanghvi, Peter J. Hotez, Alan Fenwick, Neglected tropical diseases as a cause of chronic liver disease: the case of Schistosomiasis and Hepatitis C Co-infections in Egypt, Liver International, 2013, 33, 2
  29. 29
    Rashika A.F. El Ridi, Hatem A.-M. Tallima, Novel Therapeutic and Prevention Approaches for Schistosomiasis: Review, Journal of Advanced Research, 2013, 4, 5, 467

    CrossRef

  30. 30
    Ayman El Garf, Noha Shaheen, Wafaa Gaber, Nesreen Sobhy, Prevalence and impact of chronic hepatitis C virus infection on the clinical manifestations and disease activity among patients suffering from systemic lupus erythematosus, The Egyptian Rheumatologist, 2013, 35, 1, 9

    CrossRef

  31. 31
    Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein, Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?, Acta Tropica, 2013, 128, 3, 542

    CrossRef

  32. 32
    Yousra A Mohamoud, Ghina R Mumtaz, Suzanne Riome, DeWolfe Miller, Laith J Abu-Raddad, The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis, BMC Infectious Diseases, 2013, 13, 1, 288

    CrossRef

  33. 33
    Bruno Gryseels, G Thomas Strickland, Hunter's Tropical Medicine and Emerging Infectious Disease, 2013,

    CrossRef

  34. 34
    G Thomas Strickland, Samer S El-Kamary, Hunter's Tropical Medicine and Emerging Infectious Disease, 2013,

    CrossRef

  35. 35
    Ahmedin Jemal, Freddie Bray, David Forman, Meg O'Brien, Jacques Ferlay, Melissa Center, D. Maxwell Parkin, Cancer burden in Africa and opportunities for prevention, Cancer, 2012, 118, 18
  36. 36
    Iman Maher Mansor, Lobna Yossif Ghanem, Manal Mohamed Makhlouf, Enumeration, isolation, and electron microscopic study of hematopoietic stem cells in Egyptian patients with chronic liver diseases, Comparative Clinical Pathology, 2012, 21, 6, 1349

    CrossRef

  37. 37
    SK Mahiuddin Ahammed, Abhijit Chowdhury, Hepatitis C in Punjab—Peeping into Pandora’s box!, Indian Journal of Gastroenterology, 2012, 31, 5, 223

    CrossRef

  38. 38
    Mark S. Sulkowski, Hepatitis C virus-human immunodeficiency virus coinfection, Liver International, 2012, 32,
  39. 39
    Ayman El Garf, Bassel El Zorkany, Rasha Gheith, Hala Sheba, Geilan Abdel Moneim, Kamal El Garf, Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward, Rheumatology International, 2012, 32, 9, 2691

    CrossRef

  40. 40
    Hanan Elsayed, Mohamed Elsayed, Mona Arafa, Mahmoud Elbendary, Prospective study of psychiatric side effects during antiviral therapy of chronic hepatitis C in an Egyptian sample, Middle East Current Psychiatry, 2012, 19, 2, 71

    CrossRef

  41. 41
    Gamal Esmat, Mohamed Hashem, Mona El-Raziky, Wafaa El-Akel, Suzan El-Naghy, Nehal El-Koofy, Rokaya El-Sayed, Rasha Ahmed, Mohamed Atta-Allah, Mohamed Abdel Hamid, Samer S El-Kamary, Hanaa El-Karaksy, Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children, Liver International, 2012, 32, 3
  42. 42
    Sayed Abdelwahab, Eman Rewisha, Mohamed Hashem, Maha Sobhy, Iman Galal, Walaa R. Allam, Nabeil Mikhail, Gehan Galal, Mohamed El-Tabbakh, Samer S. El-Kamary, Imam Waked, G. Thomas Strickland, Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre, Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012, 106, 2, 98

    CrossRef

  43. 43
    Bruno Gryseels, Schistosomiasis, Infectious Disease Clinics of North America, 2012, 26, 2, 383

    CrossRef

  44. 44
    M. F. Derbala, A. M. Amer, M. Almohanadi, A. John, A. Amin, A. John, M. Sharma, S. R. Alkaabi, N. Z. Al Dweik, F. Pasic, R. Yaqoob, M. T. Butt, F. M. Shebl, Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment, Journal of Viral Hepatitis, 2011, 18, 7
  45. 45
    Ponsiano Ocama, Emmanuel Seremba, Management of HIV and hepatitis C virus infections in resource-limited settings, Current Opinion in HIV and AIDS, 2011, 6, 6, 539

    CrossRef

  46. 46
    David L. Reed, Russell W. Currier, Shelley F. Walton, Melissa Conrad, Steven A. Sullivan, Jane M. Carlton, Timothy D. Read, Alberto Severini, Shaun Tyler, R. Eberle, Welkin E. Johnson, Guido Silvestri, Ian N. Clarke, Teresa Lagergård, Sheila A. Lukehart, Magnus Unemo, William M. Shafer, R. Palmer Beasley, Tomas Bergström, Peter Norberg, Andrew J. Davison, Paul M. Sharp, Beatrice H. Hahn, Jonas Blomberg, The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms, Annals of the New York Academy of Sciences, 2011, 1230, 1
  47. 47
    Abla A. Abou-Zeid, Hesham K. El-Sayegh, Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection, Scandinavian Journal of Clinical & Laboratory Investigation, 2011, 71, 6, 456

    CrossRef

  48. 48
    Nick Beeching, Anuradha Dassanayake, Tropical liver disease, Medicine, 2011, 39, 9, 556

    CrossRef

  49. 49
    Madiha M. El-Attar, Hebat-Allah G. Rashed, Eman M. Sewify, Howayda E. Hassan, A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection, Arab Journal of Gastroenterology, 2010, 11, 4, 206

    CrossRef

  50. 50
    Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin, Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010, 4, 2, 439

    CrossRef

  51. 51
    Manal M. Abdel Wahab, Lobna R. Ezz Elarab, Mohamed A. Ezz Elarab, Capecitabine plus cisplatin treatment in patients with advanced hepatocellular carcinoma, The Chinese-German Journal of Clinical Oncology, 2010, 9, 12, 718

    CrossRef

  52. 52
    Rania A. Zayed, Eman Rushdy, Doaʼa A. Saleh, Detection of HCV RNA in the Peripheral Blood Mononuclear Cells of Serum HCV RNA-Negative Egyptian Patients Under Interferon Treatment, The American Journal of the Medical Sciences, 2010, 340, 6, 435

    CrossRef

  53. 53
    Amr S. Soliman, Chu-Wei Hung, Alexander Tsodikov, Ibrahim A. Seifeldin, Mohamed Ramadan, Dina Al-Gamal, Emily L. Schiefelbein, Priyanka Thummalapally, Subhojit Dey, Kadry Ismail, Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt, Hepatology International, 2010, 4, 4, 681

    CrossRef

  54. 54
    Helen S. Te, Donald M. Jensen, Epidemiology of Hepatitis B and C Viruses: A Global Overview, Clinics in Liver Disease, 2010, 14, 1, 1

    CrossRef

  55. 55
    Doa’a A. Saleh, Fatma M. Shebl, Samer S. El-Kamary, Laurence S. Magder, Alif Allam, Mohamed Abdel-Hamid, Nabiel Mikhail, Mohamed Hashem, Soraya Sharaf, Sonia K. Stoszek, G. Thomas Strickland, Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children, Transactions of the Royal Society of Tropical Medicine and Hygiene, 2010, 104, 5, 357

    CrossRef

  56. 56
    Roba M. Talaat, Soluble Angiogenesis Factors in Sera of Egyptian Patients with Hepatitis C Virus Infection: Correlation with Disease Severity, Viral Immunology, 2010, 23, 2, 151

    CrossRef

  57. 57
    Madiha Mohamed El-Attar, Mohamed Abdel-Hamid Ahmed, Magda Shehata Hasan, Mohamed Ahmed Aly, Ahmed Medhat Nasr, Spontaneous viral clearance of chronic HCV infection in Upper Egypt: A community-based study with a 10year follow-up, Arab Journal of Gastroenterology, 2010, 11, 4, 197

    CrossRef

  58. 58
    Samer S. El-Kamary, Michelle D. Shardell, Mohamed Abdel-Hamid, Soheir Ismail, Mohamed El-Ateek, Mohamed Metwally, Nabiel Mikhail, Mohamed Hashem, Amr Mousa, Amr Aboul-Fotouh, Mohamed El-Kassas, Gamal Esmat, G. Thomas Strickland, A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis, Phytomedicine, 2009, 16, 5, 391

    CrossRef

  59. 59
    Masanori Matsuda, Hideki Fujii, Chronic Schistosomiasis Japonica is an Independent Adverse Prognostic Factor for Survival in Hepatocellular Carcinoma Patients Who Have Undergone Hepatic Resection: Clinicopathological and Prognostic Analysis of 198 Consecutive Patients, World Journal of Surgery, 2009, 33, 12, 2644

    CrossRef

  60. 60
    Curtis L. Cooper, Edward Mills, Ben O. Wabwire, Nathan Ford, Peter Olupot-Olupot, Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa, International Journal of Infectious Diseases, 2009, 13, 3, 302

    CrossRef

  61. 61
    Amany Zekry, Cytokines and liver injury in chronic HCV genotype 4 infection, Journal of Gastroenterology and Hepatology, 2009, 24, 3
  62. 62
    Amani M. Ismail, Hala N. Ziada, Hussein A. Sheashaa, Ahmed B. Shehab El-Din, Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: A glimmer of hope, European Journal of Internal Medicine, 2009, 20, 5, 490

    CrossRef

  63. 63
    E. M. Lehman, M. L. Wilson, Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality, Journal of Viral Hepatitis, 2009, 16, 9
  64. 64
    Elizabeth M. Lehman, Mark L. Wilson, Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis, International Journal of Cancer, 2009, 124, 3
  65. 65
    Abdelfattah M. Attallah, Gamal E. Shiha, Hisham Ismail, Seham E. Mansy, Rania El-Sherbiny, Ibrahim El-Dosoky, Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection, Clinical Biochemistry, 2009, 42, 6, 455

    CrossRef

  66. 66
    B. J. VENNERVALD, K. POLMAN, Helminths and malignancy, Parasite Immunology, 2009, 31, 11
  67. 67
    Volker Meier, Giuliano Ramadori, Hepatitis C virus virology and new treatment targets, Expert Review of Anti-infective Therapy, 2009, 7, 3, 329

    CrossRef

  68. 68
    Soo Hyung Ryu, Xiaofeng Fan, Yanjuan Xu, Tamerl Elbaz, Abdel-Rahman N. Zekri, Ashraf Omar Abdelaziz, Adrian M. Di Bisceglie, Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt, Journal of Medical Virology, 2009, 81, 5
  69. 69
    Fatma M. Shebl, Samer S. El-Kamary, Doa'a A. Saleh, Mohamed Abdel-Hamid, Nabiel Mikhail, Alif Allam, Hanaa El-Arabi, Ibrahim Elhenawy, Sherif El-Kafrawy, Mai El-Daly, Sahar Selim, Ayman Abd El-Wahab, Mohamed Mostafa, Soraya Sharaf, Mohamed Hashem, Scott Heyward, O. Colin Stine, Laurence S. Magder, Sonia Stoszek, G. Thomas Strickland, Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages, Journal of Medical Virology, 2009, 81, 6
  70. 70
    Xian Xia, Jun Luo, Jianling Bai, Rongbin Yu, Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis, Public Health, 2008, 122, 10, 990

    CrossRef

  71. 71
    Silvia De Sanjose, Yolanda Benavente, Claire M. Vajdic, Eric A. Engels, Lindsay M. Morton, Paige M. Bracci, John J. Spinelli, Tongzhang Zheng, Yawei Zhang, Silvia Franceschi, Renato Talamini, Elizabeth A. Holly, Andrew E. Grulich, James R. Cerhan, Patricia Hartge, Wendy Cozen, Paolo Boffetta, Paul Brennan, Marc Maynadié, Pierluigi Cocco, Ramon Bosch, Lenka Foretova, Anthony Staines, Nikolaus Becker, Alexandra Nieters, Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium, Clinical Gastroenterology and Hepatology, 2008, 6, 4, 451

    CrossRef

  72. 72
    G Thomas Strickland, Samer S El-Kamary, Paul Klenerman, Alfredo Nicosia, Hepatitis C vaccine: supply and demand, The Lancet Infectious Diseases, 2008, 8, 6, 379

    CrossRef

  73. 73
    M. Y. Elsammak, R. M. Al-Sharkaweey, M. S. Ragab, G. M. Amin, M. H. Kandil, In Egyptians, a mutation in the lymphotoxin-α gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection, Annals of Tropical Medicine & Parasitology, 2008, 102, 8, 709

    CrossRef

  74. 74
    Doa’a A. Saleh, Fatma Shebl, Mohamed Abdel-Hamid, Shaker Narooz, Nabiel Mikhail, Manal El-Batanony, Sherif El-Kafrawy, Mai El-Daly, Soraya Sharaf, Mohamed Hashem, Samer El-Kamary, Laurence S. Magder, Sonia K. Stoszek, G. Thomas Strickland, Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt, Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, 102, 9, 921

    CrossRef

  75. 75
    Elizabeth M. Lehman, Amr S. Soliman, Kadry Ismail, Ahmed Hablas, Ibrahim A. Seifeldin, Mohamed Ramadan, Hesham El-Hamzawy, Christiana S. Shoushtari, Mark L. Wilson, Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry, Hepatology Research, 2008, 38, 5
  76. 76
    S. Zakaria, R. Fouad, O. Shaker, S. Zaki, A. Hashem, S. S. E. Kamary, G. Esmat, S. Zakaria, Changing Patterns of Acute Viral Hepatitis at a Major Urban Referral Center in Egypt, Clinical Infectious Diseases, 2007, 44, 4, e30

    CrossRef

  77. 77
    Ashraf A. Tabll, Samy B. Khalil, Reem M. El-Shenawy, Gamal Esmat, Amr Helmy, Abdel Fattah Attallah, Mostafa K. El-Awady, Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C Virus, Journal of Immunoassay and Immunochemistry, 2007, 29, 1, 91

    CrossRef

  78. 78
    Gamal Esmat, Mohamed Metwally, Khalid R. Zalata, Shahinaz Gadalla, Mohamed Abdel-Hamid, Amr Abouzied, Abdel-Aziz Shaheen, Maissa El-Raziky, Hani Khatab, Sherif El-Kafrawy, Nabiel Mikhail, Laurence S. Magder, Nezam H. Afdhal, G. Thomas Strickland, Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C, Journal of Hepatology, 2007, 46, 4, 620

    CrossRef

  79. 79
    Nabiel N. Mikhail, David L. Lewis, Nabiel Omar, Hossam Taha, Amal El-Badawy, Naglaa Abdel-Mawgoud, Mohamed Abdel-Hamid, George T. Strickland, Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C–prevalent population, Gastrointestinal Endoscopy, 2007, 65, 4, 584

    CrossRef

  80. 80
    Ashraf A. Tabll ., Mohamed El-Sadany ., Serotype Analysis of Hepatitis C Virus in Patients with Liver Cirrhosis Positive and Negative for HCV RNA Using Enzyme Immunoassay, International Journal of Virology, 2007, 3, 1, 28

    CrossRef

  81. 81
    Azza El Sherbini, Shadia Abdel Mohsen, Wafaa Hasan, Salah Mostafa, Khadiga El Gohary, Azza Moneib, Abdel Hamid Abaza, The peak impact of an Egyptain outbreak of hepatitis C virus: Has it passed or has not yet occurred?, Liver International, 2007, 27, 6
  82. 82
    Nick Beeching, Anuradha Dassanayake, Tropical liver disease, Medicine, 2007, 35, 1, 49

    CrossRef

  83. 83
    Roger Williams, Global challenges in liver disease, Hepatology, 2006, 44, 3
  84. 84
    Alan Fenwick, Joanne P Webster, Schistosomiasis: challenges for control, treatment and drug resistance, Current Opinion in Infectious Diseases, 2006, 19, 6, 577

    CrossRef

  85. 85
    Stephanie R. Bialek, Norah A. Terrault, The Changing Epidemiology and Natural History of Hepatitis C Virus Infection, Clinics in Liver Disease, 2006, 10, 4, 697

    CrossRef

  86. 86
    Josep Quer, Juan I. Esteban Mur, Epidemiology and Prevention,
  87. 87
    Jama M. Darling, Stanley M. Lemon, Michael W. Fried, Hepatitis C,
  88. 88
    Michael A. Dunn, Parasitic Diseases,
  89. 89
    References,